RESEARCH USE ONLY — Not for human or animal consumption. | Order before 2PM CST for Same-Day Dispatch
Cagrilintide + RT Blend 10mg
Cagrilintide + RT Blend is a 10mg metabolic research peptide combination containing 5mg amylin analog and 5mg triple receptor agonist. Studied for appetite signaling, GLP-1 GIP glucagon receptor pathways, energy expenditure, and weight management models. Third-party HPLC tested by a US lab. Lyophilized powder. Ships from Texas.
$169.99
You save
99%+ HPLC Purity
3rd Party Verified
QR-Verified COAs
Scan & Verify
Next-Day Ship
Free US Shipping
Same-Day Dispatch
Before 2PM CST
Cagrilintide + RT Blend 10mg
Cagrilintide + RT Blend is a research peptide combination containing 5mg amylin analog and 5mg triple receptor agonist for studies on metabolic regulation, appetite signaling, GLP-1 GIP glucagon receptor pathways, energy expenditure, and weight management models. Third-party HPLC tested by a US lab. Lyophilized powder, 10mg total vial.
Research Mechanism
Cagrilintide (5mg) — Long-acting amylin and calcitonin receptor agonist (DACRA). Studied for amylin receptor agonism, appetite regulation, delayed gastric emptying, satiety signaling, and post-meal glucose control in laboratory models.
RT (5mg) — Triple receptor agonist activating GLP-1, GIP, and glucagon receptors simultaneously. Researched for metabolic effects, energy expenditure, glycemic control, and lipolysis in research settings. Half-life approximately 6 days.
Research Applications
- Cagrilintide RT combination studies
- Metabolic regulation and energy expenditure research
- Appetite signaling and satiety pathway studies
- GLP-1 GIP glucagon receptor combination assays
- Weight management models
- Glycemic control and postprandial glucose studies
- Amylin incretin synergy research
- FREE US SHIPPING
Secure payment options
- Bank-grade encryption
- SSL Secure
- Wrong Product? We Reship
- Discreet Shipping
About Cagrilintide + RT Research Peptide Blend
Cagrilintide + RT Blend is a novel synthetic peptide combination engineered for research on convergent metabolic signaling pathways. Cagrilintide is a long-acting DACRA (dual amylin and calcitonin receptor agonist) with demonstrated effects on appetite regulation, gastric emptying, and post-meal glucose control in laboratory models. RT is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors with a continuous helical structure and extended half-life of approximately 6 days. Clinical research on amylin and incretin combination therapies demonstrates synergistic effects on metabolic regulation, weight reduction, glycemic control, and energy expenditure in laboratory and clinical models. Current phase 3 research programs are evaluating similar combination approaches for chronic weight management and metabolic health outcomes.
Each batch is independently HPLC verified for purity and concentration. QR-verified COAs. 5mg Cagrilintide + 5mg RT per vial.
⚠️ Research Use Only
Not for human consumption, veterinary use, or diagnostic applications. Purchasers must be 21+ and comply with all applicable regulations.
Product Name
Cagrilintide + RT Blend 10mg
CAS Number
1415456-99-3 (Cagrilintide) / 2381089-83-2 (RT)
Molecular Formula
C₁₉₄H₃₁₂N₅₄O₅₉S₂ (Cagrilintide) / C₂₂₇H₃₄₆N₄₆O₆₉ (RT)
Form
Lyophilized Powder
Purity
99.33%
Storage
2-8°C (Refrigerate)
Shelf Life
24 months
Frequently Asked Questions
Everything researchers need to know
Reviews from Researchers
99%+ HPLC Purity
Every batch independently tested by a third-party US lab for verified purity.
QR-Verified COAs
Scan any Certificate of Analysis to see the original third-party test result instantly.
Next-Day Dispatch
Orders before 2 PM CST ship the next business day from Houston, TX.
Research Support
Our team understands peptide research. Contact us M-F, 10 AM-3 PM CST.
Related Products
